<?xml version="1.0" encoding="UTF-8"?>
<p class="p" xmlns="http://www.w3.org/1999/xhtml">
 <p class="p" xmlns=""> a Effects of CCl 4, MpEO and their combinations MpEO/CCl 4 on hepatic TBARS of control (Con) and experimental rats. Con, control group; mod, CCl 4-model group ; SL/CCl 4, silymarin 50 mg/kg + CCl 4; MpEO/CCl 4 5 mg/kg + CCl 4 group; MpEO/CCl 4 15 mg/kg + CCl 4 group; MpEO/CCl 4 40 mg/kg + CCl 4 group; MpEO 40 mg/kg group. Values are mean ± SEM for ten rats in each group. CCl 4, MpEO, MpEO/CCl 4 treated groups vs control group; * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, CCl 4 group vs (MpEO/CCl 4) group; # p &lt; 0.05, ## p &lt; 0.01, ### p &lt; 0.001. b. Effects of CCl 4, MpEO and their combinations (MpEO/CCl 4 ) on kidney TBARS of control (Con) and experimental rats. Con, control group; mod, CCl4-model group ; SL/CCl 4, silymarin 50 mg/kg + CCl 4; MpEO/CCl 4 5 mg/kg + CCl 4 group; MpEO/CCl 4 15 mg/kg + CCl4 group; MpEO/CCl 4 40 mg/kg + CCl4 group; MpEO 40 mg/kg. Values are mean ± SEM for ten rats in each group. CCl 4, MpEO, MpEO/CCl 4 treated groups vs control group; * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001, CCl 4 group vs (MpEO/CCl 4) group; # p &lt; 0.05, ## p &lt; 0.01, ### p &lt; 0.001 </p>) 
 <p class="p" xmlns=""/>) 
 <p class="p" xmlns="">Fig. 1</p>) 
</p>
